Home Podcasts Psychedelics Today
Psychedelics Today

Psychedelics Today

Psychedelics Today 774 Episodes May 11, 2026

Psychedelics Today is a podcast that covers the latest developments in psychedelic education, media, and advocacy. It explores scientific, academic, philosophical, societal, and cultural topics related to psychedelics. The show aims to lead the discussion in the rapidly evolving psychedelic ecosystem.

Episodes

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture May 11, 2026 01:43:51 Denver mushroom decriminalization changed the national conversation around psilocybin access, personal use, and grassroots psychedelic reform. In this episode of Psychedelics Today, Joe Moore speaks with Travis Tyler Fluck, an autognostic mycologist, educator, activist, end-of-life doula, and longtime Colorado mushroom community organizer. Fluck was involved in Denver's 2019 psilocybin campaign, w
PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium May 8, 2026 54:11 Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen Psychedelic Resource Center and Tasia Poinsatte of Healing Advocacy Fund. They join Joe Moore to discuss this year's symposium, how it fits into Colorado's evolving natural medicine landscape, and why Aspen has become a strong setting for serious public conversations about psychedelics. Hammel explains
PT 654 - Erica Rex - Seeing What Is There Apr 23, 2026 01:20:37 Seeing What Is There is at the center of this conversation with journalist and author Erica Rex, who joins Joe Moore to discuss her book Seeing What Is There: My Search for Sanity in the Psychedelic Era. Rex brings an unusual mix of personal experience and scientific rigor. She came to psychedelic medicine after breast cancer, participation in Roland Griffiths' clinical trial for cancer-related de
PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy Apr 16, 2026 01:19:27 ALS and ketamine therapy are at the center of this conversation with psychiatrist Dr. Michael Alpert and Peter Alberding, who was diagnosed with ALS in late 2023. Alpert is a Boston-area psychiatrist with experience in MDMA-assisted therapy research for PTSD and a private practice that includes ketamine-assisted psychotherapy. Alberding shares what it has been like to face a fatal neurodegenerat
PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow Mar 25, 2026 01:14:00 Dr. Esme Dark joins Kyle Buller for a conversation on psychedelic therapy, somatic psychotherapy, and shadow work. Based in Australia, Dark is a clinical psychologist, somatic psychotherapist, and psychedelic therapist. She shares her perspective on Australia's authorized prescriber model, the role of psychotherapy in psychedelic care, and what it means to work with the body before, during, and af
PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics Mar 19, 2026 01:22:23 MAPS co-executive directors Betty Aldworth and Ismail Ali join Psychedelics Today to talk about leading one of the most visible organizations in the psychedelic field during a period of transition. The conversation covers their move into permanent leadership, how they work together, and how MAPS is thinking about research, education, policy, and movement strategy after a difficult period for the o
PT 650 - Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape Mar 9, 2026 01:06:39 Jen Davenport joins Psychedelics Today to interview co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psychedelic ideas. Davenport is the founder of Iron Thread Partners and a graduate of the Vital psychedelic training program. Her work focuses on executive leadership, decision making, and organization
PT 649 - Melissa Lavasani and Jay Kopelman Feb 19, 2026 01:10:01 Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first respon
PT 648 - Enamory - Couples Therapy with Ketamine Feb 10, 2026 01:23:01 Enamory is a clinical practice, training institute, and nonprofit research organization focused on psychedelic assisted couples therapy. In this episode, clinical psychologists Chandra Kian and Kayla Knopp discuss their work integrating ketamine assisted psychotherapy with evidence based couples therapy models. Both guests trained as academic researchers at the University of California San Diego
PT 647 - Joshua White: Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support Jan 22, 2026 01:11:07 Fireside Project is a nonprofit that helps reduce the risks of psychedelic experiences through a free support line, coaching, education, and research. In this episode, Joshua White speaks with Psychedelics Today about why real-time support matters, what it takes to run a national hotline, and what Fireside learned after more than 30,000 conversations since launch. White shares how his background
PT 646 - Manvir Singh: Shamanism the Timeless Religion Jan 6, 2026 01:08:10 Manvir Singh joins Psychedelics Today to unpack what shamanism means and why the term matters now. Singh is an anthropologist and author of Shamanism: The Timeless Religion. He argues that shamanism is not limited to "remote" societies or the past. Instead, it reliably reappears because it helps humans manage uncertainty, illness, and the unknown. This episode is relevant for the psychedelic commu
PT 645 - Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking Dec 28, 2025 01:14:54 Oli Genn-Bash (Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving too quickly. As the founder of The Fungi Consultant, Oli works with consumers and brands to demystify functional mushrooms, with a focus on education, traceability, and realistic expectations. The conversation begins with a critique of wellness hype cyc

Recommended